[title missed]

Corresponding author: zengjiaoe, 302474717@qq.com

DOI: 10.12201/bmr.202409.00035

•  

  Abstract: [abstract missed]

  Key words: Dorzagliatin; Metformin; Obesity; Type 2 diabetic mellitus

  Submit time: 17 September 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• WANG Li, PIAO Chun-li. Efficacy and safety of Yuye decoction with metformin in type 2 diabetes mellitus: A meta-analysis. 2024. doi: 10.12201/bmr.202407.00066

  liruiyao, xujingyi, daihaoyu, sunhuiwen, wutianxing. Deep confidence network-based prediction of microvascular complications in type 2 diabetes mellitus. 2024. doi: 10.12201/bmr.202404.00021

  Yu Hong, Wang Congrong, Chen Fang, Yin Shankai, Hu Cheng, Bao Yuqian, Jia Weiping, Zhang Liang, Zhu Lin. Type 2 Diabetes Health Education Knowledge Science Mapping. 2020. doi: 10.12201/bmr.202007.00001

  Liu Shiwei. The predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in the type 2 diabeticnephropathy. 2024. doi: 10.12201/bmr.202408.00066

  wangyifan, shichaojun, maanning. Comparison of risk prediction models for atherosclerosis in type 2 diabetes mellitus. 2024. doi: 10.12201/bmr.202404.00007

  Liu hongping, Yang Jie, Pang Guoming, Xing Ying, LI Penghui, Wu Ming, Wen XXiaoxiao, Li Hongjiao, Wen Tiancai. 基于改进关联规则与Logistic回归算法集成的2型糖尿病中医证型鉴别研究. 2024. doi: 10.12201/bmr.202404.00034

  zhaochengyu. Research Progress on the Relationship between Hyperuricemia and Diabetic Peripheral Neuropathy. 2024. doi: 10.12201/bmr.202408.00019

  zhangshipei, chujinshen, xueguohui, wanfang, caojunda, chenkeqi, chenjing, liuxiaofeng, chenxueli. Elevated HE4 levels in type 2 diabetes patients are associated with proteinuria and renal impairment. 2024. doi: 10.12201/bmr.202409.00008

  Review on therapies of basic and adjuvant of diabetic foot ulcer. 2020. doi: 10.12201/bmr.202004.00003

  Liu Yanan, Zhan Ming, Han Fei. Research Progress and Prospects of Finerenone in the Treatment of Diabetic Nephropathy. 2024. doi: 10.12201/bmr.202410.00033

• ID	Submit time	Number	Download
  1	2024-09-08	bmr.202409.00035V1	Download

• Public  Anonymous  To author only Submit Comments